Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1157/13109650 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
The emerging role of Cardiovascular Magnetic Resonance in the evaluation of hypertensive heart disease.
BMC Cardiovasc Disord
May 2017
Asklipiion Voulas, Athens, Greece.
Background: Arterial hypertension is the commonest cause of cardiovascular death. It may lead to hypertensive heart disease (HHD), including heart failure (HF), ischemic heart disease (IHD) and left ventricular hypertrophy (LVH).
Main Body: According to the 2007 ESH/ESC guidelines, the recommended imaging technique is echocardiography (echo), when a more sensitive detection of LVH than that provided by ECG, is needed.
High Risk versus Proportional Benefit: Modelling Equitable Strategies in Cardiovascular Prevention.
PLoS One
June 2016
CNRS, UMR 5558, Laboratoire de Biométrie et Biologie Evolutive, Service de Pharmacologie Clinique et Essais Thérapeutiques, Lyon, France; INSERM, CIC 201, EPICIME, Lyon, France; Hop L Pradel, CHU Lyon, Lyon, France.
Objective: To examine the performances of an alternative strategy to decide initiating BP-lowering drugs called Proportional Benefit (PB). It selects candidates addressing the inequity induced by the high-risk approach since it distributes the gains proportionally to the burden of disease by genders and ages.
Study Design And Setting: Mild hypertensives from a Realistic Virtual Population by genders and 10-year age classes (range 35-64 years) received simulated treatment over 10 years according to the PB strategy or the 2007 ESH/ESC guidelines (ESH/ESC).
Clinical management of patients with hypertension and high cardiovascular risk in specialised centers and in general practice. Analysis from an Italian Survey Questionnaire.
Nutr Metab Cardiovasc Dis
September 2015
Division of Cardiology, Department of Clinical and Molecular Medicine, Faculty of Medicine and Psychology, University of Rome "Sapienza", Sant'Andrea Hospital, Rome, Italy; IRCCS Neuromed, Pozzilli, IS, Italy.
Background And Aim: Hypertension control remains poorly achieved worldwide, despite the use of modern diagnostic tools and advanced therapeutic strategies. We aimed to evaluate the preferences expressed by either specialised physicians (SPs) or general practitioners (GPs) for the clinical management of hypertension and high cardiovascular risk in Italy.
Methods And Results: A predefined questionnaire was anonymously administered to a large community sample of physicians, stratified according to clinical expertise.
Eligibility to treatment and economic effect of the implementation of the new U.S. or European Society of Hypertension/European Society of Cardiology hypertension guidelines.
J Hypertens
April 2015
aDepartment of Medicine, Internal Medicine, Lausanne University Hospital (CHUV) and Faculty of Biology and Medicine bDivision of Clinical Pathophysiology, Lausanne University Hospital (CHUV), Lausanne, Switzerland.
Objective: To evaluate the population and economic impact of implementing the new Joint National Committee (JNC) or European Society of Hypertension (ESH)/European Society of Cardiology (ESC) hypertension guidelines in the Swiss population.
Methods: Cross-sectional, population-based sample (6708 participants) collected between 2003 and 2006 in the city of Lausanne, Switzerland. Blood pressure categories were defined according to both the JNC (JNC-7 and JNC-8) and the ESH/ESC (2007 and 2013) guidelines.
2013 ESH/ESC guidelines for the management of arterial hypertension: what has changed in daily clinical practice?
High Blood Press Cardiovasc Prev
March 2015
Hypertension Outpatient Unit, Cardiology Department, "KAT" General Hospital of Attica, 14561, Athens, Greece,
This is a review article aiming to make focus on the changes made in the European Society of Hypertension (ESH)/European Society of Cardiology (ESC) guidelines for the management of arterial hypertension with some criticism for each element discussed in the text. Given that in the real world clinical practice physicians would hardly spend the time needed for studying the 77 pages manuscript of the recently released 2013 ESH/ESC hypertension guidelines, the present review summarizes all the significant updates (along with their clinical implications) compared to the 2007 ESH/ESC hypertension guidelines and the 2009 reappraisal document.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!